K Number
K030712
Device Name
AMSURE URETHRAL CATHETERIZATION TRAY
Date Cleared
2003-05-23

(78 days)

Product Code
Regulation Number
876.5130
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The AMSure Urethral Catherization Tray is intended for use in the drainage of urine from the bladder.
Device Description
Not Found
More Information

Not Found

Not Found

No
The 510(k) summary describes a simple medical device (catheterization tray) and contains no mention of AI, ML, image processing, or performance studies related to algorithmic analysis.

No.
Explanation: The device is intended for the drainage of urine, which is a supportive or diagnostic function, not a therapeutic one. It does not treat, cure, mitigate, or prevent disease.

No
Explanation: The device is intended for the drainage of urine from the bladder, which is a therapeutic or interventional function, not a diagnostic one.

No

The 510(k) summary describes a "Urethral Catherization Tray," which is a physical medical device used for draining urine. There is no mention of software in the provided text.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "drainage of urine from the bladder." This is a direct medical intervention on the patient's body, not a test performed on a sample taken from the body to diagnose a condition.
  • Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing a biological sample (urine, blood, tissue, etc.)
    • Providing diagnostic information about a disease or condition
    • Using reagents or analytical methods

An IVD is a medical device used to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. The AMSure Urethral Catherization Tray is a device used for a procedure (catheterization) to drain urine, which is a therapeutic or management action, not a diagnostic test.

N/A

Intended Use / Indications for Use

The AMSure Urethral Catherization Tray is intended for use in the drainage of urine from the bladder.

Product codes

78 FCM

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

bladder (for drainage of urine)

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.5130 Urological catheter and accessories.

(a)
Identification. A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use).(b)
Classification. (1) Class II (performance standards).(2) Class I for the ureteral stylet (guidewire), stylet for gastrourological catheter, ureteral catheter adapter, ureteral catheter connector, and ureteral catheter holder. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

0

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.

Public Health Service

MAY 2 3 2003

Food and Drug Administration 9200 Corporate Boulevard * Rockville MD 20850

Ching Ching Seah, Ph.D. Director of Research, Development and Regulatory Affairs Amsino International, Inc. 4501 Brickell Privado Ontario, CANADA 91761

Re: K030712

Trade/Device Name: AMSure ™ Urethral Catheterization Tray Regulation Number: 21 CFR 8876.5130 Regulation Name: Urological catheter and accessories Regulatory Class: II Product Code: 78 FCM Dated: February 27, 2003 Received: March 6, 2003

Dear Dr. Seah:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act). You may, therefore, market the device, subject to the general controls provisions of Act. However, you are responsible to determine that the medical devices you use as components in the tray have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your tray. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality

1

Page 2 – Dr. Ching Ching Seah

systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

In addition, we have determined that your device kit contains Povidone Iodine Swabsticks, which are subject to regulation as a drug.

Our substantially equivalent determination does not apply to the drug components of your device. We recommend you first contact the Center for Drug Evaluation and Research before marketing your device with the drug components. For information on applicable Agency requirements for marketing this drug, we suggest you contact:

Director, Division of Drug Labeling Compliance (HFD-310) Center for Drug Evaluation and Research Food and Drug Administration 5600 Fishers Lane Rockville, Maryland 20857 (301) 594-0101

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation, please contact the Office of Compliance at (301) 594-4616. Also, please note the regulation entitled. "Misbranding by reference to premarket notification"(21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll free number (800) 638-2041 or (301) 443-6597, or at its Internet address http://www.fda.gov/dsma/dsmamain.html.

Sincerely vours.

David A. Ingram

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Image /page/2/Picture/0 description: The image shows the word "AMSINO" in a stylized, serif font. The letters are all capitalized and appear to be in bold. The overall impression is a clean and professional logo or heading.

Page 5 of 8

Indications for Use Statement

510(k) Number: (if known)

ান পুলিশ

K030712

Device Name:

AMSure Uretheral Catheterization Tray

Indications for Use:

The AMSure Urethral Catherization Tray is intended for use in the drainage of urine from the bladder.

Particle Production Comments of the Research and Comments of Concerner Comments of Concerner Comments of Concerner Comments of Concerner

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use
(Per 21 CFR 801. 109)

OR

Over-The-Counter Use
-------------------------------------
(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Devices
510(k) NumberK030712